Literature DB >> 21888767

Aminoguanidine and N-acetyl-cysteine supress oxidative and nitrosative stress in EAE rat brains.

Srdjan Ljubisavljevic1, Ivana Stojanovic, Dusica Pavlovic, Dusan Sokolovic, Ivana Stevanovic.   

Abstract

Experimental autoimmune encephalomyelitis (EAE) is a well-established animal model of human multiple sclerosis (MS). We have evaluated the role of oxidative and nitrosative stress, as the causal factors in the development of EAE, responsible for the damage of cardinal cellular components, such as lipids, proteins and nucleic acids, resulting in demyelination, axonal damage, and neuronal death. EAE was induced in female Sprague-Dawley rats, 3 months old (300±20 g), by immunization with myelin basic protein in combination with Complete Freund's adjuvant (CFA). The animals were divided into seven groups: control, EAE, CFA, EAE+aminoguanidine (AG), AG, EAE+N-acetyl-L-cysteine (NAC) and NAC. The animals were sacrificed 15 days after EAE induction, and the levels of nitrosative and oxidative stress were determined in 10% homogenate of the whole encephalitic mass. In EAE rats, brain NO production and MDA level were significantly increased (P<0.001) compared to the control values, whereas AG and NAC treatment decreased both parameters in EAE rats compared to EAE group (P<0.001). Glutathione (GSH) was reduced (P<0.001) in EAE rats in comparison with the control and CFA groups, but increased in EAE+AG and EAE+NAC group compared to the EAE group (P<0.01). Superoxide dismutase (SOD) activity was significantly decreased (P<0.001) in the EAE group compared to all other experimental groups. The clinical expression of EAE was significantly decreased (P<0.05) in the EAE groups treated with AG and NAC compared to EAE rats, during disease development. The obtained results prove an important role of oxidative and nitrosative stress in the pathogenesis of EAE, whereas AG and NAC protective effects offer new possibilities for a modified combined approach in MS therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21888767      PMCID: PMC6837682          DOI: 10.1179/1351000211Y.0000000007

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  43 in total

1.  Contrasting roles for nitric oxide and peroxynitrite in the peroxidation of myelin lipids.

Authors:  R C van der Veen; L J Roberts
Journal:  J Neuroimmunol       Date:  1999-03-01       Impact factor: 3.478

Review 2.  Regulation of the expression of inducible nitric oxide synthase.

Authors:  Andrea Pautz; Julia Art; Susanne Hahn; Sebastian Nowag; Cornelia Voss; Hartmut Kleinert
Journal:  Nitric Oxide       Date:  2010-05-08       Impact factor: 4.427

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Selective inhibition of the inducible nitric oxide synthase by aminoguanidine.

Authors:  T P Misko; W M Moore; T P Kasten; G A Nickols; J A Corbett; R G Tilton; M L McDaniel; J R Williamson; M G Currie
Journal:  Eur J Pharmacol       Date:  1993-03-16       Impact factor: 4.432

5.  Protective effect of N-acetylcysteine supplementation on mitochondrial oxidative stress and mitochondrial enzymes in cerebral cortex of streptozotocin-treated diabetic rats.

Authors:  Sukhdev S Kamboj; Rajat Sandhir
Journal:  Mitochondrion       Date:  2010-11-07       Impact factor: 4.160

6.  Microglial cell activation and proliferation precedes the onset of CNS autoimmunity.

Authors:  Eugene D Ponomarev; Leah P Shriver; Katarzyna Maresz; Bonnie N Dittel
Journal:  J Neurosci Res       Date:  2005-08-01       Impact factor: 4.164

7.  Microglia are the major cellular source of inducible nitric oxide synthase during experimental herpes encephalitis.

Authors:  Cristina P Marques; Maxim C-J Cheeran; Joseph M Palmquist; Shuxian Hu; James R Lokensgard
Journal:  J Neurovirol       Date:  2008-05       Impact factor: 2.643

8.  Appearance of inducible nitric oxide synthase in the rat central nervous system after rabies virus infection and during experimental allergic encephalomyelitis but not after peripheral administration of endotoxin.

Authors:  A M Van Dam; J Bauer; W K Man-A-Hing; C Marquette; F J Tilders; F Berkenbosch
Journal:  J Neurosci Res       Date:  1995-02-01       Impact factor: 4.164

9.  Multiple sclerosis: distribution of inflammatory cells in newly forming lesions.

Authors:  Andrew P D Henderson; Michael H Barnett; John D E Parratt; John W Prineas
Journal:  Ann Neurol       Date:  2009-12       Impact factor: 10.422

10.  SOD3 reduces inflammatory cell migration by regulating adhesion molecule and cytokine expression.

Authors:  Juha P Laurila; Lilja E Laatikainen; Maria D Castellone; Mikko O Laukkanen
Journal:  PLoS One       Date:  2009-06-04       Impact factor: 3.240

View more
  18 in total

1.  Reproducibility measurement of glutathione, GABA, and glutamate: Towards in vivo neurochemical profiling of multiple sclerosis with MR spectroscopy at 7T.

Authors:  Hetty Prinsen; Robin A de Graaf; Graeme F Mason; Daniel Pelletier; Christoph Juchem
Journal:  J Magn Reson Imaging       Date:  2016-06-28       Impact factor: 4.813

2.  N-Acetylcysteine attenuates tumor necrosis factor alpha levels in autoimmune inner ear disease patients.

Authors:  Shresh Pathak; Corey Stern; Andrea Vambutas
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

3.  Hesperidin, a Citrus Flavonoid, Has the Ameliorative Effects Against Experimental Autoimmune Encephalomyelitis (EAE) in a C57BL/J6 Mouse Model.

Authors:  Osman Ciftci; Cemal Ozcan; Ozden Kamisli; Aslı Cetin; Nese Basak; Bilal Aytac
Journal:  Neurochem Res       Date:  2015-04-10       Impact factor: 3.996

4.  The Use of Agmatine Provides the New Insight in an Experimental Model of Multiple Sclerosis.

Authors:  Milica Ninkovic; Ivana Stevanovic; Ivana Stojanovic; Srdjan Ljubisavljevic; Jelena Basic; Predrag Peric
Journal:  Neurochem Res       Date:  2015-07-04       Impact factor: 3.996

5.  Sex Difference in Oxidative Stress Parameters in Spinal Cord of Rats with Experimental Autoimmune Encephalomyelitis: Relation to Neurological Deficit.

Authors:  Mirjana Dimitrijević; Jelena Kotur-Stevuljević; Zorica Stojić-Vukanić; Ivana Vujnović; Ivan Pilipović; Mirjana Nacka-Aleksić; Gordana Leposavić
Journal:  Neurochem Res       Date:  2016-11-03       Impact factor: 3.996

Review 6.  Multiple sclerosis: molecular mechanisms and therapeutic opportunities.

Authors:  Djordje Miljković; Ivan Spasojević
Journal:  Antioxid Redox Signal       Date:  2013-04-22       Impact factor: 8.401

7.  Lipopolysaccharide Binding Protein and Oxidative Stress in a Multiple Sclerosis Model.

Authors:  Begoña M Escribano; Francisco J Medina-Fernández; Macarena Aguilar-Luque; Eduardo Agüera; Montserrat Feijoo; Fe I Garcia-Maceira; Rafael Lillo; Patricia Vieyra-Reyes; Ana I Giraldo; Evelio Luque; René Drucker-Colín; Isaac Túnez
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

8.  Effects of IFN-β1a and IFN-β1b treatment on the expression of cytokines, inducible NOS (NOS type II), and myelin proteins in animal model of multiple sclerosis.

Authors:  Natalia Lubina-Dąbrowska; Adam Stepień; Grzegorz Sulkowski; Beata Dąbrowska-Bouta; Józef Langfort; Małgorzata Chalimoniuk
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2017-03-15       Impact factor: 4.291

Review 9.  Role of diet in regulating the gut microbiota and multiple sclerosis.

Authors:  John Michael S Sanchez; Ana Beatriz DePaula-Silva; Jane E Libbey; Robert S Fujinami
Journal:  Clin Immunol       Date:  2020-03-07       Impact factor: 3.969

10.  Neuroprotective effect of nitric oxide donor isosorbide-dinitrate against oxidative stress induced by ethidium bromide in rat brain.

Authors:  Omar M E Abdel-Salam; Yasser Ashry Khadrawy; Nadia A Mohammed
Journal:  EXCLI J       Date:  2012-03-29       Impact factor: 4.068

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.